¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ras Guanine Nucleotide Exchange Factors"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® exchange transfusion ÇÑ±Û ±³È¯¼öÇ÷
¼³¸í   
  ÇÑÂÊÀ¸·Î´Â ÇǸ¦ »Ì¾Æ³»¸é¼­ ´Ù¸¥ ÂÊÀ¸·Î´Â °°Àº ¾çÀÇ ÇǸ¦ ³Ö¾î ¿Â¸öÀÇ ÇǸ¦ °¥¾Æ ³Ö´Â ¼öÇ÷¹æ¹ý. °«³­¾ÆÀÌÀÇ ¿ëÇ÷º´ÀÇ Ä¡·á¹ýÀ¸·Î ¾´´Ù.
¿µ¹® guanine ÇÑ±Û ±¸¾Æ´Ñ
¼³¸í   
  DNA³ª RNAÀÇ ±¸¼º¿ä¼Ò·Î ¿°±â ÁßÀÇ Çϳª.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • guanine
    ±¸¾Æ´Ñ
  • diphosphopyridine nucleotide
    ÀÌÀλêÇǸ®µò´ºÅ¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • single nucleotide polymorphism
    ´ÜÀÏ´ºÅ¬·¹¿ÀƼµå´ÙÇüÅÂ
  • anion exchange resin
    À½À̿±³È¯¼öÁö
  • alveolar gas exchange
    ÆóÆ÷°¡½º±³È¯, ÇãÆÄ²Ê¸®°¡½º±³È¯
  • base exchange
    ¿°±â±³È¯
  • countercurrent exchange
    ¿ª·ù±³È¯
  • cation exchange
    ¾çÀ̿±³È¯
  • cation exchange resin
    ¾çÀ̿±³È¯¼öÁö
  • chromatid exchange
    ¿°»öºÐü±³È¯
  • exchange
    ±³È¯
  • exchange coupling
    ±³È¯°áÇÕ
  • exchange transfusion
    ±³È¯¼öÇ÷
  • gas exchange ratio
    °¡½º±³È¯ºñÀ²
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • guanine
    ±¸¾Æ´Ñ
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • exchange
    ±³È¯
  • base exchange
    ¿°±âġȯ
  • plasma exchange
    Ç÷À屳ȯ(¼ú)
  • exchange transfusion
    ±³È¯¼öÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • guanine
    ±¸¾Æ´Ñ
  • complementary nucleotide
    »óº¸´ºÅ¬·¹¿ÀƼµå
  • diphosphopyridine nucleotide
    ÀÌÀλêÇǸ®µò´ºÅ¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • air-fluid exchange
    °ø±â¾×ü±³È¯(¼ú)
  • alveolar gas exchange
    ÆóÆ÷°¡½º±³È¯, ÆóÆ÷±âü±³È¯
  • anion exchange resin
    À½À̿±³È¯¼öÁö
  • base exchange
    ¿°±âġȯ
  • cation exchange resin
    ¾çÀ̿±³È¯¼öÁö
  • chromatid exchange
    ¿°»öºÐü±³È¯
  • countercurrent exchange
    ¿ª·ù±³È¯
  • exchange coupling
    ±³È¯°áÇÕ
  • ion exchange chromatography
    À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • exchange
    ±³È¯
  • exchange transfusion
    ±³È¯¼öÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ras gene
    ras À¯ÀüÀÚ(¡­ë¶îîí­)
  • ras protein
    ras ´Ü¹é(¡­Ó±ÛÜ)
  • Guanine
    ±¸¾Æ´Ñ
  • Insulin-like growth factors
    Àν¶¸°¾ç(å×)¼ºÀå(à÷íþ)È£¸£¸ó
  • guanine gout
    ±¸¾Æ´ÑÅëdz(¡­÷Ôù¦).
  • hypoxanthine guanine phosphoribosyl transferase(hgprt)
    hypoxanthine guanine phospho ribosyl
  • hypoxanthine-guanine phosphoribosyl transferse
    ÇÏÀÌÆ÷ÀÜÆ¾¾Æ´Ñ Æ÷½ºÆ÷¸®º¸½ÇÆ®¶õ½ºÆä¶óÁ¦
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • quality factors
    Ư¼º ¿ä¼Ò, Áú ¿ä¼Ò
  • Flow-limited exchange
    À¯·®Á¦Çѱ³È¯(ð¤ùÚÎßüµ)
  • air-fluid exchange
    °ø±â¾×ü±³È¯
  • alveolar gas exchange
    ÆóÆ÷±âü±³È¯(¡­Îß üµ)
  • alveolar gas exchange
    ÆóÆ÷°¡½º±³È¯(¡­Îß üµ).
  • anion exchange chromatography
    À½À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ras gene
    ras À¯ÀüÀÚ(¡­ë¶îîí­)
  • ras protein
    ras ´Ü¹é(¡­Ó±ÛÜ)
  • guanine gout
    ±¸¾Æ´ÑÅëdz(¡­÷Ôù¦).
  • hypoxamthine guanine
  • hypoxanthine guanine phosphoribosyl transferase(hgprt)
    hypoxanthine guanine phospho ribosyl
  • hypoxanthine-guanine phosphoribosyl transferse
    ÇÏÀÌÆ÷ÀÜÆ¾¾Æ´Ñ Æ÷½ºÆ÷¸®º¸½ÇÆ®¶õ½ºÆä¶óÁ¦
  • diphosphopyridine nucleotide =DPN
    ÀÌÀλêÇǸ®µò ´©Å¬·¹¿ÀƼµå.
  • nicotinamide adenine nucleotide
    ´ÏÄÚÆ¾¾Æ¹Ìµå¾Æµ¥´Ñ´©Å¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀŸÀ̵å
  • nucleotide
    ´©Å¬¸®¿ÀŸÀÌ.
  • triphosphopyridine nucleotide
    »ïÀλêÇǸ®µò´©Å¬·¹¿ÀƼµå.
  • coagulation factors
    ÀÀ°íÀÎÀÚ(¡­ì×í­)
  • exogenous factors
    ¿ÜÀμº ¿ä¼Ò(èâì×àõ é©áÈ).
  • exogenous factors
    ¿ÜÀμº ¿ä¼Ò(¡­é©áÈ).
  • factors
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • guanine-nucleotide-binding protein
    ±¸¾Æ´Ñ´©Å¬·¹¿ÀŸÀÌµå °áÇÕ ´Ü¹éÁú(Ì¿ùêÓ±ÛÜòõ)
  • ras gene
    ras À¯ÀüÀÚ(ë¶îîí­)
  • nucleotide exchange reaction
    ´©Å¬¸®¿ÀŸÀÌµå ±³È¯¹ÝÀÀ(ÎßüµÚãëë)
  • fibroblast growth factors
    ¼¶À¯¾Æ¼¼Æ÷ ¼ºÀÚÀÎÀÚ (àéë«ä´á¬øàà÷íþì×í­)
  • guanine
    ±¸¾Æ´Ñ
  • suppressor factors
    ¾ï¾Ð(ÀÚ) ÀÎÀÚ(åääâ(í­)ì×í­)
  • catalytic exchange method
    Ã˸ű³È¯¹ý(õºØÚÎßüµÛö)
  • deuterium exchange
    Áß¼ö¼Ò ±³È¯(ñìâ©áÈÎßüµ)
  • electron-exchange resin
    ÀüÀÚ±³È¯ ¼öÁö(ï³í­Îßüµâ§ò·)
  • exchange diffusion
    ±³È¯ È®»ê (Îßüµüªß¤)
  • hydrogen exchange
    ¼ö¼Ò ±³È¯(â©áÈÎßüµ)
  • hydrogen iostope exchange
    ¼ö¼Ò µ¿À§¿ø¼Ò ±³È¯(â©áÈÔÒêÈêªáÈÎßüµ)
  • ion-exchange chromatography
    À̿±³È¯(Îßüµ) Å©·Î¸¶Åä±×·¡ÇÇ
  • ion-exchange resin
    À̿±³È¯(Îßüµ) ¼öÁö(â§ò·)
  • isotope exchange
    µ¿À§¿ø¼Ò ±³È¯(ÔÒêÈêªáÈÎßüµ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • quality factors
    Ư¼º¿ä¼Ò, Áú¿ä¼Ò
  • exchange coupling
    ±³È¯°áÇÕ
  • exchange diffusion
    ±³È¯È®»ê
  • exchange guide wire
    ±³È¯¿ëÀ¯µµÃ¶»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GN gaze nystagmus; glomerulonephritis; glucose nitrogen [ratio]; gnotobiote; graduate nurse; gram-negat...
GNAT guanine nucleotide-binding protein, alpha-transducing
GNB ganglioneuroblastoma; gram-negative bacillus; guanine nucleotide-binding [protein]
GNBT guanine nucleotide-binding protein, beta transducing
RAS   1) Reticular Activating(Activation) System
  2) Renal Artery Stenosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GEF Guanine nucleotide Exchange Factors
GEP guanine nucleotide exchange protein
Ras GAP Ras GTPase activating protein
Ras p21(ras
GDI Guanine nucleotide dissociation inhibitor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • controlling factors in facial growth
    ¾È¸é ¼ºÀåÀÇ Á¶Àý ¿äÀÎ
  • dihydroxy-propoxy-methyl guanine
    ´ÙÀÌÇÏÀ̵å·Ï½Ã-ÇÁ·ÎÆø½Ã-¸ÞÆ¿ ±¸¾Æ´Ñ
  • nucleotide adenosine triphosphate
    ´ºÅ¬·¹¿ÀƼµå ¾Æµ¥³ë½Å Æ®¸®Æ÷½ºÆäÀÌÆ®
  • Ras.
    ¹®Áö¸£±â
    L. rasuraeÀÇ ¾àÀÚ
  • anion exchange chromatography
    À½À̿ ±³È¯ Å©·Î¸¶Åä±×·¡ÇÇ
  • anion exchange resin
    À½À̿ ±³È¯ ¼öÁö
  • chloride-bicarbonate exchange
    ¿°¼Ò Áßź»ê À̿ ±³È¯
  • exchange
    ±³È¯
  • exchange diffusion
    ±³È¯ È®»ê
  • exchange of electrolyte
    ÀüÇØÁú ±³È¯
  • exchange transfusion
    ±³È¯ ¼öÇ÷
    ȯÀÚÀÇ ÀüÇ÷¾×À» °øÇ÷ÀÚÀÇ Ç÷¾×À¸·Î ġȯÇÏ´Â ¹æ¹ýÀÌ¸ç ½Å»ý¾ÆÀÇ ¿ëÇ÷¼º ºóÇ÷ µî¿¡ »ç¿ëµÈ´Ù.
  • hydrogen ion exchange
    ¼ö¼Ò À̿ ±³È¯
  • ion exchange
    À̿ ±³È¯
  • ion exchange strengthening
    À̿ ±³È¯ °­È­
  • sister chromatid exchange test
    ÀڸŠ¿°»ö ºÐü ±³È¯ °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
p21(ras) farnesyl-protein transferase <enzyme> Transfers the farnesyl moiety from farnesyl pyrophosphate to a cysteine in p21(ras) proteins; composed of an alpha and a beta subunit
Registry number: EC 2.5.1.-
Synonym: farnesyl-protein transferase p21(ras), ras p21 farnesyl-protein transferase, protein-cysteine farnesyltransferase, pc farnesyltransferase, protein farnesyltransferase, p21(ras) farnesyltransferase, farnesyl-protein transferase-alpha, farnesyl-protein transferase-beta, ft alpha, ft beta, caax farnesyltransferase, ftase enzyme
(26 Jun 1999)
ras <oncogene> One of a family of oncogenes, first identified as transforming genes of Harvey and Kirsten murine sarcoma viruses. (Name from rat sarcoma because Harvey virus, though a mouse virus, obtained its transforming gene during passage in a rat). Transforming protein coded is p21ras, a GTP-binding protein with GTPase activity, that resembles regulatory G-proteins.
(18 Nov 1997)
ras protein geranylgeranyltransferase <enzyme> Mammalian enzyme transfers geranylgeranyl groups to a cysteine residue fourth from the c-terminal group of a p21 ras protein, prefers leucine at the cooh terminus; see also rhoa geranylgeranyltransferase and protein geranylgeranyltransferase
Registry number: EC 2.5.1.-
Synonym: geranylgeranyltransferase ras protein, ras protein gg transferase, ggtase I, caax geranylgeranyl transferase
(26 Jun 1999)
ras proteins Small GTP-binding proteins encoded by ras genes (genes, ras) that play a critical role in normal cellular growth, differentiation, and development, and have the potential for malignant transformation. Two of the major ras proteins include the normal cellular form, proto-oncogene protein p21(ras), and the malignant form, oncogene protein p21(ras).
(12 Dec 1998)
genes, ras Family of retrovirus-associated DNA sequences (ras) originally isolated from harvey (h-ras, ha-ras, rash) and kirsten (k-ras, ki-ras, rask) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both h-ras and k-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related n-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein.
(12 Dec 1998)
proto-oncogene protein p21(ras) Cellular protein encoded by the c-ras genes. The protein has GTPase activity and is involved in transmembrane signal transduction as a guanine nucleotide binding protein. Elevated levels of p21 c-ras have been associated with neoplasia.
(12 Dec 1998)
h-ras <oncogene> A point-mutated proto-oncogene that is found in melanoma and in carcinoma of colon, lung and pancreatic tissue.
(10 Oct 1997)
oncogene protein p21(ras) Transforming protein encoded by ras oncogenes. Point mutations in the cellular ras gene (c-ras) can also result in a mutant p21 protein that can transform mammalian cells. Oncogene protein p21(ras) has been directly implicated in human neoplasms, perhaps accounting for as much as 15-20% of all human tumours.
(12 Dec 1998)
k-ras <oncogene> A proto-oncogene that has point mutations and is associated with melanoma, thyroid carcinoma, and acute myelogenous and lymphoblastic leukaemia.
(09 Oct 1997)
guanine <biochemistry, molecular biology> One of the constituent bases of nucleic acids, nucleosides and nucleotides.
(18 Nov 1997)
guanine aminase <enzyme> An enzyme that catalyses the deamination of guanine to form xanthine.
Chemical name: Guanine aminohydrolase
Registry number: EC 3.5.4.3
(12 Dec 1998)
guanine cell A cell whose cytoplasm contains glistening crystals of guanine.
(05 Mar 2000)
guanine deaminase <enzyme> An enzyme that catalyses the deamination of guanine to form xanthine.
Chemical name: Guanine aminohydrolase
Registry number: EC 3.5.4.3
(12 Dec 1998)
guanine deoxyribonucleotide Deoxyguanosine monophosphate, a hydrolysis product of DNA.
Synonym: guanine deoxyribonucleotide.
(05 Mar 2000)
guanine ribonucleotide A major component of ribonucleic acids.
Synonym: guanine ribonucleotide, guanosine 5'-monophosphate.
Guanylic acid reductase (GMP reductase), an enzyme that catalyses the reaction of GMP with NADPH producing IMP, NH3, and NADP+; a part of the purine salvage pathway.
Guanylic acid synthetase (GMP synthetase), an enzyme catalyzing the reaction of l-glutamine, XMP, and ATP to produce GMP, l-glutamate, AMP, and pyrophosphate; a key step in purine biosynthesis.
Acronym: GMP
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • ras Guanine Nucleotide Exchange Factors - »õâ A family of GUANINE NUCLEOTIDE EXCHANGE FACTORS that are specific for RAS PROTEINS.
    Synonyms : ras Guanine Nucleotide Exchange Factor, ras-GEF, ras-GEFs, rasGEF, ras GEF, ras GEFs
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • RAS
    reliability;availability & serviceability ½Å·Úµµ;À̿밡´Éµµ;º¸¼ö °¡´Éµµ(ÄÄÇ»ÅÍ ´É·Â Æò°¡ÀÇ ÁÖ¿ä¼Ò)
  • guanine
    ±¸¾Æ´Ñ(DAN,RNA¸¦ ±¸¼ºÇϴ Ǫ¸° ¿°±âÀÇ Çϳª)
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå(ÇÙ»êÀÇ ±¸¼º¼ººÐ)
  • nucleotide sequence
    (»ýÈ­)´ºÅ¬·¹¿ÀƼµå ¹è¿­
  • exchange
    ±³È¯ÇÏ´Ù
  • in exchange for
    ~¸¦ ..·Î ¹Ù²Ù´Ù
  • Labor Exchange
    Á÷¾÷¼Ò°³¼Ò
  • New York Stock Exchange
    ´º¿åÁõ±Ç °Å·¡¼­(¼¼°è ÃÖ´ëÀÇ)
  • Post Exchange
    ¸ÅÁ¡
  • Royal Exchange
    (the ~)·±´ø Áõ±Ç °Å·¡¼Ò(R.E)
  • base exchange
    ¸ÅÁ¡
  • commodity exchange
    »óǰ°Å·¡¼Ò
  • corn exchange
    °î¹° °Å·¡¼Ò
  • cultural exchange
    ¹®È­±³·ù 
  • effective exchange rate
    (±ÝÀ¶)½ÇÈ¿ ȯ½Ã¼¼(ȯÀ²)(±¹Á¦ÅëÈ­±â±ÝÀÌ ´çÇØ±¹°ú ´Ù¸¥ ÁÖ¿ä 20°³±¹ ÅëÈ­ÀÇ È¯½Ã¼¼¸¦ º¹ÇÕ½ÃÄÑ »êÃâÇÏ´Â Áö¼ö)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á